MIRA INFORM REPORT

 

 

Report Date :

01.10.2013

 

IDENTIFICATION DETAILS

 

Name :

FRESENIUS KABI INDIA PRIVATE LIMITED

 

 

Registered Office :

A-3, MIDC, Ranjangaon Ganpati, Taluka Shirur, Ranjangaon, District Pune - 412220, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

02.02.1995

 

 

Com. Reg. No.:

25-014017

 

 

Capital Investment / Paid-up Capital :

Rs. 636.286 Millions

 

 

CIN No.:

[Company Identification No.]

U24231PN1995PTC014017

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PNEF00178D

 

 

PAN No.:

[Permanent Account No.]

AAACF2614E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Distributor of Pharmaceutical Products and Medical Devices.

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 2666000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

Liquidity position of the company is adversely affected due to continuous loss incurred by the company from its operations.

 

However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some cautions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Amol Kulkarni

Designation :

Company Secretary

Contact No.:

91-2138-232284

Date :

30.09.2013

 

 

LOCATIONS

 

Registered Office/ Factory :

A-3, MIDC, Ranjangaon Ganpati, Taluka Shirur, Ranjangaon, District Pune - 412220, Maharashtra, India

Tel. No.:

91-2138-232283-5/ 671600

Fax No.:

91-2138-232282

E-Mail :

fkipl@fresenius-kabi.com

dharmesh.thaker@fresenius-kabi.com

amol.kulkarni@fresenius-kabi.com

ashish1972@gmail.com

amolk@yahoo.com 

Website :

www.fresenius-kabi.co.in  

Location :

Owned

 

 

Corporate Office :

Echelon Institutional Area, Plot No-11, Sector 32, Gurgaon - 122001, Haryana, India

Tel. No.:

91-124-4885000/ 3325000

Fax No.:

91-124-4885003

 

 

Mumbai Office :

301, 3rd Floor , Wagh Apartments, 3 Park Road, Vile Parle (East), Mumbai - 400057, Maharashtra, India

Tel. No.:

91-22-26171047

Fax No.:

91-22-26135406

E-Mail :

mumbai.fkipl@fresenius-kabi.com

 

 

Pune Office :

5th Floor, A-wing, Ashoka Plaza, Pune-Nagar Road, Survey No.32/2, Vadgaon Sheri, Viman Nagar, Pune - 411014, Maharashtra, India

Tel. No.:

91-20-26634701-707

Fax No.:

91-20-26634710

 

 

Headquarters of Region Asia Pacific :

Rm 5101-23, 51/F Sun Hung Kai Centre, 30 Harbour Road, Wanchai, Hong Kong

Tel. No.:

+852 2116 2683

Fax No.:

+852 2116 3420

E-Mail :

asia-pacific@fresenius-kabi.com

 

 

DIRECTORS

 

AS ON 28.09.2012

 

Name :

Mr. Abhay Gajanan Joshi

Designation :

Whole-time director

Address :

Flat No. 403, A Wing, Om Avishkar Housing Society, Sneh Paradise, Paud Road, Pune – 411038, Maharashtra, India

Date of Birth/Age :

10.06.1956

Date of Appointment :

01.08.2012

DIN No.:

00027226

 

 

Name :

Mr. Satish Bapusaheb Kulkarni

Designation :

Director

Address :

308, Espace Nirvana Country, Sector 50, Gurgaon - 122003, Haryana, India

Date of Birth/Age :

03.12.1965

Date of Appointment :

20.10.2011

DIN No.:

00309263

 

 

Name :

Mr. Sanjay Kumar Gupta

Designation :

Whole-time director

Address :

202, Auriga, Zicron Apartment, Viman Nagar, Pune – 411014, Maharashtra, India

Date of Birth/Age :

21.05.1964

Qualification :

B.Sc., FCA, CPA, CIA

Experience :

24 Years

Date of Appointment :

10.07.2009

PAN No.:

AAHPG4706C

DIN No.:

02295921

 

 

Name :

Juergen Wolfgang Lauterbach

Designation :

Director

Address :

Flat B 12 F, Tower 3, 68, Bel Air Peak Avenue, Belair On Peak Wahfu, Hong Kong

Date of Birth/Age :

15.01.1969

Date of Appointment :

06.10.2010

DIN No.:

03277553

 

 

Name :

Christoph Wilhelm Funke

Designation :

Director

Address :

Buchenstrasse 8 Emmeln Haren EMS Germany 49733

Date of Birth/Age :

06.03.1968

Date of Appointment :

23.04.2012

DIN No.:

05258462

 

 

Name :

Subrroto Banerjee

Designation :

Managing director

Address :

Row House, 49 Konark Pooram, Kondhwa KD, Pune – 411048, Maharashtra, India

Date of Birth/Age :

11.11.1958

Date of Appointment :

01.08.2012

DIN No.:

05345071

 

 

KEY EXECUTIVES

 

Name :

Mr. Amol Laxman Kulkarni

Designation :

Company Secretary

Address :

Flat No. D9, Sakhai Plaza, S.No.87/15B, Pune – 411038, Maharashtra, India

Date of Birth/Age :

06.10.1979

Date of Appointment :

26.08.2009

PAN No.:

AQCPK8468Q

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 28.09.2012

 

Names of Shareholders

 

No. of Shares

 

Fresenius Kabi AG, Germany

 

59128620

Fresenius Kabi Deutschland GmbH, Germany

 

4500010

 

 

 

Total

 

 

63628630

 

 

AS ON 28.09.2012

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

100.00

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Distributor of Pharmaceutical Products and Medical Devices.

 

 

Products/ Services :

ITC Code No.

Product Descriptions

30032000

Large Volume Intravenous Fluid

 

 

PRODUCTION STATUS (AS ON 31.03.2012)

 

Licensed and installed capacity (as certified by the management)

31.03.2012

Intravenous fluids

42000000

 

Note:

Licensed capacity is not stated in view of abolition of industrial licensing for the products manufactured by the Company.

Installed capacity is per annum as certified by management.

 

 

GENERAL INFORMATION

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Deutsche Bank, Hazarimal Somani Marg, Fort, Mumbai - 400001, Maharashtra, India

 

 

Facilities :

 

SECURED LOANS

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

SHORT TERM BORROWINGS

 

 

Term loans from banks

8.950

11.624

 

 

 

Total

 

8.950

11.624

 

LONG TERM BORROWINGS

 

1 The sales tax deferral loan of the Company is an interest free loan which is repayable in annual installments commencing from the year 2009-10. Information is disclosed based upon assessment orders received till date from the respective authorities.

 

2 Loan from Holding Company represents External Commercial Borrowing (ECB) of Euro 1.2 million from Fresenius Kabi AG, the holding company which will be repayed after 3 years from the date of drawdown i.e. 25 February 2014. Interest rate is fixed for the period of 6 months from the date of disbursement, which is based on the 6 months Euro Libor plus a margin of 175 basis point .p.a. Thereafter, the interest will be fixed annualy based on the respective Euro Libor plus applicable margin. The applicable margin is subject to change but the total interest rate will not exceed 300 basis points over 6 months Euro Libor.

 

SHORT TERM BORROWINGS

 

The above cash credit accounts are secured by way of first charge hypothecation of the Company's present and future machinery spares, tools and accessories, stock in trade consisting of raw material, work-in-progress, semi-finished goods, finished goods and book debts. These cash credit facility carries an interest rate ranging between 15.75% to 16.75% p.a.

 

1.     Both the above Cash Credit and Buyers Credit facilities are secured by a corporate guarantee given by Fresenius Kabi AG to the extent of Rs.450.000 Millions.

 

2.     The Cash Credit carries an interest rate ranging between 9.25 % to 12% p.a. computed on a monthly basis, based upon the actual amount utilized and repayable on demand.

 

3.     The Buyers Credit carries an interest rate which is linked to 6 months Libor plus 150 bps o 250 bps

 

 

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B S R and Company

Chartered Accountants

Address :

703, 7th Floor, Godrej Castlemaine, Next to Ruby Hall Clinic, Bund Garden Road, Pune – 411001, Maharashtra, India

Tel. No.:

91-20-30585764/ 30585765

Fax No.:

91-20-30585775

Income-tax PAN of auditor or auditor's firm :

AAAFB9852F

 

 

Holding company :

Fresenius Kabi AG

 

 

Fellow Subsidiary company :

·         Fresenius Kabi Austria Gmbh

·         Fresenius Kabi Medical Care

·         Fresenius Kabi (Singapore) Limited

·         Sino Swed Pharmaceutical Corp.

·         Fresenius Kabi Korea Limited

·         Fresenius Kabi Asia Pacific

·         Fresenius Kabi Deutschland GmBH

·         Fresenius Kabi Singapore PTE Limited

·         Fresenius Kabi Thailand Limited

·         Fresenius Medical Care India Private Limited [U24231DL2006FTC147436]

·         Fresenius Kabi Oncology Limited [L24231DL2003PLC119441]

·         Fresenius Netcare GmbH

·         Fresenius Kabi AB Sweden

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

75,000,000

Equity Shares

Rs. 10/- each

Rs. 750.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

63,628,630

Equity Shares

Rs. 10/- each

Rs. 636.286 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

636.286

636.286

(b) Reserves & Surplus

 

30.132

107.822

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

666.418

744.108

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

109.603

107.417

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

6.300

6.550

(d) long-term provisions

 

51.476

20.537

Total Non-current Liabilities (3)

 

167.379

134.504

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

299.834

227.603

(b) Trade payables

 

532.066

284.212

(c) Other current liabilities

 

52.298

123.628

(d) Short-term provisions

 

194.554

158.448

Total Current Liabilities (4)

 

1078.752

793.891

 

 

 

 

TOTAL

 

1912.549

1672.503

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

641.798

517.002

(ii) Intangible Assets

 

4.436

5.267

(iii) Capital work-in-progress

 

0.000

15.953

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

61.061

35.312

(e) Other Non-current assets

 

8.456

7.267

Total Non-Current Assets

 

715.751

580.801

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

641.270

400.453

(c) Trade receivables

 

461.766

286.144

(d) Cash and cash equivalents

 

15.513

26.861

(e) Short-term loans and advances

 

78.249

378.244

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

1196.798

1091.702

 

 

 

 

TOTAL

 

1912.549

1672.503

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

636.286

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

625.713

4] (Accumulated Losses)

 

 

(484.380)

NETWORTH

 

 

777.619

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

8.586

2] Unsecured Loans

 

 

380.736

TOTAL BORROWING

 

 

389.322

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

1166.941

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

556.080

Capital work-in-progress

 

 

1.411

 

 

 

 

INVESTMENT

 

 

0.051

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

315.508

 

Sundry Debtors

 

 

259.347

 

Cash & Bank Balances

 

 

18.898

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

402.386

Total Current Assets

 

 

996.139

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

206.696

 

Other Current Liabilities

 

 

161.075

 

Provisions

 

 

18.969

Total Current Liabilities

 

 

386.740

Net Current Assets

 

 

609.399

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

1166.941

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

 

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

TOTAL                                     (A)

2691.107

1896.972

1646.354

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                     (B)

2697.818

1840.893

1572.804

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

(6.711)

56.079

73.550

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

23.698

21.787

23.551

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

(30.409)

34.292

49.999

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

47.280

67.803

115.109

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                 (G)

(77.689)

(33.511)

(65.110)

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

(77.689)

(33.511)

(65.110)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB Value of Exports

351.940

382.352

338.230

 

 

Others

0.000

64.642

9.781

 

TOTAL EARNINGS

351.940

446.994

348.011

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Material and Packing Material

188.527

136.884

128.538

 

 

Traded Goods

656.629

585.070

526.534

 

TOTAL IMPORTS

845.156

721.954

655.072

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

(1.22)

(0.53)

(1.02)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

(2.89)
(1.77)
(3.95)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(4.06)
(2.02)
(4.19)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.12)
(0.05)
(0.08)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.61

0.45

0.50

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.11

1.38

2.58

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

CURRENT MATURITIES OF LONG TERM DEBT

 

Particulars

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

31.03.2010

(Rs. In Millions)

 

 

 

 

Current maturities of long-term debt

3.934

91.008

NA

 

 

 

 

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

90086897

26/07/2004

17,000,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, WAKDEWADI, PUNE - 411003, MAHARASHTRA, INDIA

-

2

80062948

09/05/1997

27,000,000.00

STATE BANK OF INDIA

INDUSTRIAL FINANCE BRANCH, WAKDEWADI, PUNE - 411003, MAHARASHTRA, INDIA

-

 

 

UNSECURED LOANS

 

UNSECURED LOANS

31.03.2012

(Rs. In Millions)

31.03.2011

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Foreign currency term loans from others

82.009

75.888

Deferred payment liabilities

27.594

31.529

SHORT TERM BORROWINGS

 

 

Term loans from banks

290.884

215.979

 

 

 

Total

 

400.487

323.396

 

 

Note:

The Registered office of the company has been shifted from Heritage House, 6-E, Ramabai Ambedkar Road, Pune - 411001, Maharashtra, India to the present address w.e.f.01.07.2011.

 

 

BACKGROUND

 

Fresenius AG had established its business operations in India through a joint venture namely Fresenius Mafatlal Medicals Limited (FMML). In 1998, Fresenius Kabi AG acquired 100% equity interest in this joint venture and accordingly it was renamed as Fresenius Kabi India Private Limited (‘FKIPL’ or ‘the Company’).

 

The Company is engaged primarily in production and distribution of intravenous fluids, medical devices, and oncology drugs which is broadly classified under one business i.e. catering to the healthcare segment

 

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Other building

·         Plant and equipment

·         Other plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Motor vehicles

·         Office equipment

·         Other equipments

·         Leasehold improvements

·         Computer software


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 62.78

UK Pound

1

Rs. 101.42

Euro

1

Rs. 84.67

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.